Cargando…

Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study

BACKGROUND: Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and low social support, these patients are at high risk for medication non-adherence. Established treatment facilities face challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: Allemann, Samuel S., Dürsteler, Kenneth M., Strasser, Johannes, Vogel, Marc, Stoeckle, Marcel, Hersberger, Kurt E., Arnet, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559800/
https://www.ncbi.nlm.nih.gov/pubmed/28814330
http://dx.doi.org/10.1186/s12954-017-0182-x
_version_ 1783257579713986560
author Allemann, Samuel S.
Dürsteler, Kenneth M.
Strasser, Johannes
Vogel, Marc
Stoeckle, Marcel
Hersberger, Kurt E.
Arnet, Isabelle
author_facet Allemann, Samuel S.
Dürsteler, Kenneth M.
Strasser, Johannes
Vogel, Marc
Stoeckle, Marcel
Hersberger, Kurt E.
Arnet, Isabelle
author_sort Allemann, Samuel S.
collection PubMed
description BACKGROUND: Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and low social support, these patients are at high risk for medication non-adherence. Established treatment facilities face challenges to accommodate these complex patients within their setting. Electronic medication management aids (e-MMAs) might be appropriate to simultaneously monitor and improve adherence for these patients. CASE PRESENTATION: We report the first long-term experiences with a novel remote electronic medication supply model for two opioid-dependent patients with HIV. John (beginning dementia, 52 years, 6 tablets daily at 12 am) and Mary (frequent drug holidays, 48 years, 5–6 tablets daily at 8 pm) suffered from disease progression due to non-adherence. We electronically monitored adherence and clinical outcomes during 659 (John) and 953 (Mary) days between July 2013 and April 2016. Both patients retrieved over 90% of the pouches within 75 min of the scheduled time. Technical problems occurred in 4% (John) and 7.2% (Mary) of retrievals, but on-site support was seldom required. Viral loads fell below detection limits during the entire observation period. CONCLUSIONS: Continuous medication supply and persistence with treatment of over 1.7 years, timing adherence of more than 90%, and suppressed HIV viral load are first results supporting the feasibility of the novel supply model for patients on opioid-assisted treatment and polypharmacy.
format Online
Article
Text
id pubmed-5559800
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55598002017-08-18 Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study Allemann, Samuel S. Dürsteler, Kenneth M. Strasser, Johannes Vogel, Marc Stoeckle, Marcel Hersberger, Kurt E. Arnet, Isabelle Harm Reduct J Case Study BACKGROUND: Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and low social support, these patients are at high risk for medication non-adherence. Established treatment facilities face challenges to accommodate these complex patients within their setting. Electronic medication management aids (e-MMAs) might be appropriate to simultaneously monitor and improve adherence for these patients. CASE PRESENTATION: We report the first long-term experiences with a novel remote electronic medication supply model for two opioid-dependent patients with HIV. John (beginning dementia, 52 years, 6 tablets daily at 12 am) and Mary (frequent drug holidays, 48 years, 5–6 tablets daily at 8 pm) suffered from disease progression due to non-adherence. We electronically monitored adherence and clinical outcomes during 659 (John) and 953 (Mary) days between July 2013 and April 2016. Both patients retrieved over 90% of the pouches within 75 min of the scheduled time. Technical problems occurred in 4% (John) and 7.2% (Mary) of retrievals, but on-site support was seldom required. Viral loads fell below detection limits during the entire observation period. CONCLUSIONS: Continuous medication supply and persistence with treatment of over 1.7 years, timing adherence of more than 90%, and suppressed HIV viral load are first results supporting the feasibility of the novel supply model for patients on opioid-assisted treatment and polypharmacy. BioMed Central 2017-08-16 /pmc/articles/PMC5559800/ /pubmed/28814330 http://dx.doi.org/10.1186/s12954-017-0182-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Study
Allemann, Samuel S.
Dürsteler, Kenneth M.
Strasser, Johannes
Vogel, Marc
Stoeckle, Marcel
Hersberger, Kurt E.
Arnet, Isabelle
Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title_full Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title_fullStr Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title_full_unstemmed Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title_short Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
title_sort novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559800/
https://www.ncbi.nlm.nih.gov/pubmed/28814330
http://dx.doi.org/10.1186/s12954-017-0182-x
work_keys_str_mv AT allemannsamuels novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT durstelerkennethm novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT strasserjohannes novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT vogelmarc novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT stoecklemarcel novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT hersbergerkurte novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy
AT arnetisabelle novelremoteelectronicmedicationsupplymodelforopioiddependentoutpatientswithpolypharmacyfirstlongtermcasestudy